The Latin America market for Insulin is
expected to reach USD 3,760.7 million by 2020, according to a new study
by Grand View Research, Inc. Growing prevalence of diabetes (type I and
type II) coupled with government initiatives to develop insulin in
markets such as Brazil by providing medical and financial aid to the
population in the form of subsidies and the entrance of multinational
companies such as Novo Nordisk, Sanofi Aventis, etc is expected to drive
regional insulin market. Affordability of medicines is perceived to be a
key challenge for market development, as a significant part of the
population may not be able to afford the product.
In 2013, Type II applications lead the
regional market, with revenue of USD 1,183.7 million and are expected to
grow at a CAGR of 15.8 % from 2014 to 2020. Type I applications are
expected to have faster growth, at an estimated CAGR of 20.3 % from 2014
to 2020.
The report “Latin America (Brazil,
Argentina, Chile, Mexico, Colombia, Venezuela) Insulin Market (Rapid
Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes,
Analogs, Recombinant) Analysis And Segment Forecasts To 2020,” is
available now toGrand View Researchcustomers and can also be purchased
directly at
http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market
http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market
Further key findings from the study suggest:
• Long acting products dominated insulin
demand in Latin America, with estimated revenue of USD 548.6 million in
2013. Other leading products include rapid acting and premixed analogs,
with the latter expected to grow at a CAGR of 14.3 % from 2014 to 2020.
• In 2013, Analog was a dominant insulin source and is expected to grow at a CAGR of 17.7 % from 2014 to 2020.
• R&D initiatives, changing lifestyle affecting health of people specially children and growing rate of old aged (above 40) population are also expected to have a positive influence on market demand.
• In 2013, Brazil was the largest regional insulin market in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR of 18.2 % from 2014 to 2020.
• Some of the key manufacturers in Latin American insulin market include Sanofi Aventis, Novo Nordisk, Nanjing Xinbai Pharmaceutical Co. Ltd, Takeda Pharmaceuticals, Eli Lilly and Company.
• In 2013, Analog was a dominant insulin source and is expected to grow at a CAGR of 17.7 % from 2014 to 2020.
• R&D initiatives, changing lifestyle affecting health of people specially children and growing rate of old aged (above 40) population are also expected to have a positive influence on market demand.
• In 2013, Brazil was the largest regional insulin market in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR of 18.2 % from 2014 to 2020.
• Some of the key manufacturers in Latin American insulin market include Sanofi Aventis, Novo Nordisk, Nanjing Xinbai Pharmaceutical Co. Ltd, Takeda Pharmaceuticals, Eli Lilly and Company.
For the purpose of this study, Grand
View Research has segmented the Asia Pacific Insulin market on the basis
of product, application, source and region:
• Insulin Product Outlook
• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting
• Insulin Application Outlook
• Type II and Other Diabetes
• Type I Diabetes
• Insulin Source Outlook
• Human Recombinant
• Analogs
• Insulin Regional Outlook
• Brazil
• Argentina
• Chile
• Mexico
• Colombia
• Venezuela
• Peru
• Rest of Latin America
• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting
• Insulin Application Outlook
• Type II and Other Diabetes
• Type I Diabetes
• Insulin Source Outlook
• Human Recombinant
• Analogs
• Insulin Regional Outlook
• Brazil
• Argentina
• Chile
• Mexico
• Colombia
• Venezuela
• Peru
• Rest of Latin America
About Grand View Research
Grand View Research, Inc. is a market
research and consulting company that provides off-the-shelf, customized
research reports and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from
technology to chemicals, materials and energy. With a deep-seated
understanding of varied business environments, Grand View Research
provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com
No comments:
Post a Comment